trump glp-1 medicaid low-cost plan a likely boost for Eli Lilly, Novo Nordisk Direct-To-Consumer Drug Portals Offer Lower

Novo Nordisk (the maker of Wegovy) and Eli Lilly (the maker of Zepbound) have both decreased the price of these weight loss drugs for people who are paying out of pocket or do not have insurance coverage for weight loss drugs

Things changed one day last fall when his wife shared her blood test results

The team here at Montare can help guide you to the best treatment for Mental Health and provide an assessment to determine the best care to fit your needs

Healthcare providers adjust GLP-1 dosages based on patient responses

Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone in the body to help regulate blood sugar and appetite

Adjusted EBITDA was $44.3 million for Q1 compared to $91.1 million for the first quarter of 2025